Comprehensive Report on Viral Vector Manufacturing Market Grow at CAGR of +20% by 2025: Know About Technological Advancements, Competition Status, and Top Key Players
The gene therapy arena has gained significant momentum from the last decade in research areas such as cancer treatment, vaccination, rare genetic diseases, etc. The most common vector being used in these gene modification studies include viruses and plasmid DNAs. Gene modification therapies very rarely receive regulatory approval; however, the viral vectors are extensively used for preclinical and clinical trials. These vectors which are used for commercial trials are manufactured using cGMP guidelines, and are highly documented with master cell...
View full press release